Next Generation Sequencing Market Trend, Application, Sales and Forecast 2025

Next Generation Sequencing Market Trend, Application, Sales and
Forecast 2025
“The Global Next Generation Sequencing Market is anticipated to reach USD 21.4
billion by 2025. The Market Research Report provides in-depth industry overview
of Methodology, Opportunities, Scope, Market Variables, Trends & Strategy
Framework.”
The Global Next Generation Sequencing Market is anticipated to reach USD 21.4 billion by 2025. NGS market is
expected to show a tremendous growth on account of its wide applications in the treatment of cancer. NGS is the
process of identifying accurate order of nucleotides within a RNA or a DNA molecule. Advancement of NGS has
helped biological and medical discovery and research. It has helped in various applied fields, which includes
biotechnology, forensic research, virology and medical diagnosis. NGS has made possible sequencing of DNA of
various species including the human genome.
Introduction of advanced genetic sequencing and development of advance techniques for whole genomes are the
major drivers contributing to the overall market growth. Increasing incidences of cancer and infectious diseases
coupled with aging population is expected to fuel the demand for these technologies.
Further, the overall cost of genome sequencing is expected to reduce drastically on account of rapid development
through research and innovation. High capacity genome sequencing has been contributing significantly towards the
market growth.
NGS has wide applications in the field of exome and genome sequencing. They are widely used in the treatment of
infectious disease and cancer. NGS has shown a key presence in pathogen analysis, which has been helpful in the
treatment of infectious diseases. The need for effective diagnosis for cancer and high growing usage of
combinational biomarkers are other factors contributing to the growth of the market in recent years. NGS has been
mostly a topic of research and development in the previous decade.
Request Sample Copy of this Market Research @ https://www.millioninsights.com/industryreports/next-generation-sequencing-ngs-market/request-sample

At present, they find applications in the field of oncology, prenatal testing, HLA testing, idiopathic diseases, and
medical research. Research and development in the field of HLA and prenatal testing have provided new avenues
to doctors in gaining insights during organ matching and organ rejection.
The development in the treatment of genetic anomalies and diseases with the help of prenatal genome sequencing
has been driving the NGS market. This technology has also helped the pharmaceutical companies in developing
essential drugs for the treatment of cancer and infectious diseases. Growing concerns and increasing incidences of
cancer is expected to be the major driving factor for the development of NGS.
NGS in the field of organ transplant provides great opportunities over the forecast period. It is important that the
characteristics of both the donors and the acceptors match for a successful transplant. NGS helps in studying the
immune response to the transplanted organ. Medical tourism development in countries including the U.S, Israel,
Singapore and Australia provide bright prospects for overall growth of the market.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/next-generation-sequencing-ngs-market
Next generation sequencing market is segmented as target, genome, exon and resequencing. The largest share is
held by target sequencing followed by genome sequencing.
Development of whole genome sequencing capabilities is expected to show a significant growth over the forecast
period. Whole genome technology is relatively new and is gaining popularity with the development of high
throughput. This high throughput has helped in reducing complications associated with whole genome sequencing.
NGS includes sample enrichment, DNA tagging, library preparation, sample quality assurance, DNA quantification,
data storage, genetic data assembly, analysis and interpretation. With the increase in volume of whole genome
sequencing, next generation data analysis is expected to observe a significant growth over the forecast period.
See More Reports of this Category by Million Insights @
https://www.millioninsights.com/industry/biotechnology
Government regulatory bodies play a vital role in overall development and usage of these technologies. Medical
device manufacturers in the U.S. are under the strict vigilance of Food and Drug Administration (FDA). In 2013, FDA
approved four next generation gene sequencing devices which is expected to help physicians in taking a broader
look at the patient’s genetic makeup. Two of the approved devices is expected to help in detecting DNA changes in
the treatment of cystic fibrosis.
North America is expected to observe highest demand in the global industry on account of the well-developed
healthcare sector and implementation of advanced research infrastructure. Similarly, Western Europe is expected
to show a substantial demand over the forecast period on account of increasing emphasis by the regional

government on healthcare facilities coupled with the stringent regulatory framework. Asia Pacific and the Middle
East are expected to observe significant growth on account of the increasing government initiatives to establish
proper healthcare infrastructure in developing economies including China, India, Japan and UAE.
The NGS market is dominated by few players with the help of proprietary platforms. The key industry players include
Life Sciences (Roche), Thermo Fischer Scientific, Illumina and Pacific Biosciences.
Other major players operating in the market include Partek Inc., Genomatix Software GmbH, Macrogen Inc., Life
Technologies Corp, Perkin Elmer inc., Oxford Nanopore Technologies Ltd., Knome Inc, Agilent Technologies Inc.,
Biomatters Ltd., CLC Bio (Qiagen), Pacific Biosciences, BGI (Beijing Genomics Institute), DNASTAR Inc, GATC Biotech
and Qiagen N.V.
Market Segmentation
NGS Outlook, by Application (Revenue, USD Million; 2014 - 2025)
Reproductive Health
Oncology
HLA Typing/Immune System Monitoring
Metagenomics, Epidemiology & Drug Development
Agrigenomics & Forensics
Consumer Genomics
Clinical Investigation
NGS Outlook, by Technology (Revenue, USD Million; 2014 - 2025)
Targeted Sequencing Analysis
Whole Genome Sequencing
Whole Exome Sequencing
NGS Outlook, by Workflow (Revenue, USD Million; 2014 - 2025)
Pre-sequencing
Sequencing
NGS Outlook, by End-use (Revenue, USD Million; 2014 - 2025)
Academic Research
Clinical Research
Hospitals & Clinics

Pharma & Biotech Entities
Other Users
NGS Outlook, by Region (Revenue, USD Million; 2014 - 2025)
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
Get in touch
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our
representatives strive to understand diverse client requirements and cater to the same with the most
innovative and functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist, USA
Email: ryan@millioninsights.com
Global Headquarters
Million Insights
Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States
Phone: 1-408-610-2300
Email: sales@millioninsights.com
Asia Pacific
Million Insights
Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India
Phone: 91-20-65300184
Email: sales@millioninsights.com